The Role of Preoperative Neutrophil-to-Lymphocyte Ratio and C-reactive Protein in Predicting the Severity of Cholelithiasis With Cholecystitis

术前中性粒细胞与淋巴细胞比值和C反应蛋白在预测胆囊炎合并胆结石严重程度中的作用

阅读:2

Abstract

INTRODUCTION: Acute calculous cholecystitis is a common surgical condition with variable clinical severity. Early identification of severe disease remains challenging. Inflammatory biomarkers such as neutrophil-to-lymphocyte ratio (NLR) and C-reactive protein (CRP) have been proposed as simple indicators of systemic inflammation and disease severity. The present study aimed to evaluate the association of preoperative NLR and CRP levels with the severity of calculous cholecystitis and their relationship with clinical outcomes. MATERIALS AND METHODS: This prospective observational study was conducted over two years in a tertiary care centre and included 48 patients diagnosed with cholelithiasis with cholecystitis and undergoing laparoscopic cholecystectomy. Preoperative NLR and CRP levels were recorded within 24 hours prior to surgery. Based on intraoperative findings and histopathology, patients were classified into simple, purulent, and gangrenous cholecystitis. Correlation analysis was performed to assess the relationship between inflammatory markers and duration of hospital stay. RESULTS: The mean age was 45.08 ± 13.78 years, with female predominance 30 (62.5%). Simple cholecystitis was most common 23 (47.9%), followed by purulent 15 (31.3%) and gangrenous 10 (20.8%). Median NLR and CRP were 2.67 and 10.55 mg/dl, respectively. Both NLR and CRP increased significantly with worsening severity (p < 0.001). NLR showed a strong positive correlation with CRP (r = 0.641, p = 0.001). NLR (r = 0.427, p = 0.001) and CRP (r = 0.539, p = 0.001) correlated significantly with longer hospital stay. Age and BMI were not significantly associated with severity. CONCLUSION: Preoperative NLR and CRP levels are significantly associated with the severity of calculous cholecystitis and duration of hospitalization. These readily available biomarkers may serve as useful adjuncts in clinical severity assessment.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。